![]() |
Computational Drug Design Course_ Part II Join us & Enjoy the Best & the Most Informative International Short term Courses Ever By Prof. Afshin Fassihi Full Professor of Medicinal Chemistry Dr. Fahimeh Ghasemi Assistant Professor of Biomedical Engineering |
Introduction
Although thousands of potentially active molecules are being detected each year, concerns such as poor pharmacokinetics profiles and the emergence of resistance in microbial, viral and cancer diseases along with the vast number of drug targets puts forward the de novo drug design as an important task to achieve.
Massive costs and time-consuming nature of laboratory procedures have convinced the pharmaceutical companies and research groups to take the advantage of computational techniques as serious alternative methods. A serious need for a comprehensive insight to the drug design concepts and application of computational approaches to design biologically active molecules is felt in both academy and industry. Two basic approaches have been proposed for computational drug design, relying on either the structure of the biologically active molecules (ligands) or the structure of the macromolecular target of the biologically active ligands. Ligand-based and structure-based drug design approaches are the main principles of all computational drug design courses after the recent advances in computational methods and software’s as well as the evolution of hardware technology.
Computational Drug Design Course, Part II begins with an overview of the most applied structure-based drug design (SBDD) methods. It continues with teaching the details of pharmacophore modelling and molecular docking simulation techniques as two of the most popular methods in SBDD.
Duration: 30 Hours-5 Days
Registration Date: July 10st - Aug 6th, 2019
Initiation Date: Sep 1st - 5th, 2019
Course Location: Tadbir International Education Center
Contact Info
- Dr. Hosseini
- Telephone: 98-31-3792662
- Mrs. Hashemi
- Telephone: 98-31-37927653